Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Johannes Fredebohm

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030349802. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 3

  1. The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators. Co-author DOI 10.18632/oncotarget.19882↗
  2. Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine. Co-author DOI 10.1242/jcs.124768↗
  3. Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system. Co-author DOI 10.1371/journal.pone.0048503↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jörg D. Hoheisel · 3 shared papers, 2012–2017 · strength 0.14
  2. Michael Boettcher · 2 shared papers, 2012–2013 · strength 0.08
  3. Diana Behrens · 1 shared paper, 2017 · strength 0.06
  4. Malte Buchholz · 1 shared paper, 2017 · strength 0.06
  5. Brajesh Pratap Kaistha · 1 shared paper, 2017 · strength 0.06
  6. Thilo Hackert · 1 shared paper, 2017 · strength 0.06
  7. Oliver Strobel · 1 shared paper, 2017 · strength 0.06
  8. Thomas Mathias Gress · 1 shared paper, 2017 · strength 0.06
  9. Nathalia A. Giese · 1 shared paper, 2012 · strength 0.03
  10. Jörg Tost · 1 shared paper, 2012 · strength 0.03
  11. Matthias M. Gaida · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.